C001
OVEREXPRESSION OF HOMOLOGOUS REPAIR PROTEINS IN HUMAN PAPILLOMAVIRUS POSITIVE HEAD AND NECK SQUAMOUS CELL CARCINOMA BY IMMUNOHISTOCHEMISTRY ANALYSIS. A POTENTIAL TARGET FOR MOLECULAR THERAPIES.
Immunotherapy and Other Adjuvant Treatments
Andrew J Holcomb, MD1, Sufi Thomas, PhD1, Yelizaveta Shnayder, MD1, Rashna Madan, MD1, Ossama Tawfik, MD, PhD1, Nicholas Wallace, PhD2
1University of Kansas Medical Center, 2Kansas State University
C002
DEFINED GENETIC ALTERATIONS AS A BIOMARKER PREDICTING PROGNOSIS IN HPV-ASSOCIATED HEAD AND NECK CANCER.
Andrew B Sewell, MD, Michael Hajek, MD, Cassie Pan, BS, Tejas Sather, BS, Wendell G Yarbrough, MD, MMHC, Natalia Issaeva, PhD
Yale University
C003
PLASMACYTOID DENDRITIC CELLS ARE DISTINCTLY IMMUNOSTIMULATORY IN HPV-POSITIVE HNSCC
Kate Poropatich, Sandeep Samant, Bin Zhang
Northwestern University
C004
HIGH THROUGHPUT DRUG TESTING IDENTIFIES AGENTS WITH SELECTIVE ACTIVITY IN HPV-POSITIVE AND HPV-NEGATIVE CELL LINES
Farhad Ghasemi, BSc1, Morgan D Black, BSc, MSc1, Alessandro Datti, PhD2, John W Barrett, PhD1, John Yoo, MD1, Kevin Fung, MD1, S D MacNeil, MD, MSc1, Anthony C Nichols, MD1
1Western University, 2Lunenfeld Tanenbaum Research Institute
C005
LEVEL OF LYMPH NODE METASTASIS ADDS PROGNOSTIC VALUE TO AMERICAN JOINT COMMITTEE ON CANCER NODAL STAGING FOR SQUAMOUS CELL CARCINOMA OF THE FLOOR OF MOUTH
Oral Cancer
Alexander N Goel, BA, Suraj A Dhanjani, Albert Y Han, MD, Karam W Badran, MD, Maie A St. John, MD, PhD
Department of Head and Neck Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA
C006
INHIBITION OF TRKB RECEPTOR ON THE MIGRATION OF HUMAN SCHWANN CELL AND ORAL TONGUE SQUAMOUS CELL CARCINOMA IN VITRO
Liliana Ein, MD1, Olena Bracho, BS1, Paula Monje, PhD1, Cristina Fernandez, PhD2, Giovana Thomas, MD1, Donald Weed, MD1, Zoukaa Sargi, MD, MPH1, Christine Dinh, MD1
1University of Miami Miller School of Medicine, 2University of Central Florida Burnett School of Biomedical Sciences
C007
NODAL YIELD AND LOG ODDS RATIO ARE ASSOCIATED WITH SURVIVAL OUTCOMES IN EARLY STAGE CLINICALLY NODE-NEGATIVE ORAL CAVITY SQUAMOUS CELL CARCINOMA
Anuraag S Parikh, MD, Ayaz Khawaja, MD, Besher Assi, Joseph Zenga, MD, Mark A Varvares, MD
Massachusetts Eye and Ear Infirmary
C008
FACTORS PREDICTIVE OF ELECTIVE NECK DISSECTION (END) IN PATIENTS WITH CN0 HARD PALATE AND UPPER GINGIVAL SCC AND THE IMPACT OF END ON SURVIVAL
A Obayemi, MD1, M Cohen, MD1, R Rahmati, MD2, J Migliacci1, J C Cracchiolo1, B Roman1
1Memorial Sloan Kettering Cancer Center, 2Columbia University Medical Center
C009
VALIDATION OF AN UPDATED GRAPHIC EDUCATION TOOL IN AN ORAL RINSE POINT-OF-CARE ASSAY TO AID IN THE DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
Michael J Donovan, Dr1, Greg Ginn2, Elizabeth Franzmann, MD3
1Icahn School of Medicine at Mt. Sinai, 2Vigilant Biosciences, 3University of Miami
C010
A POPULATION-BASED ANALYSIS OF A RARE NASOPHARYNGEAL MALIGNANCY: 1677 CASES OF LYMPHOEPITHELIAL CARCINOMA
Neel R Sangal, BA, Sarangdev Vaidya, BA, Monica C Azmy, BS, Jean Anderson Eloy, MD, FACS, Soly Baredes, MD, FACS, Richard C Park, MD, FACS
New Jersey Medical School
AHNS Annual Meeting
Held during the Combined Otolaryngology Spring Meetings (COSM)
April 18–19, 2018 Gayloard National Resortand Convention CenterNational Harbor, MD
Tips on Using this Site
Locate an abstract by entering any author's surname into the search box. You may also search by keyword or program ID number.
Broaden your search by typing only a few letters of a keyword; however, do not append the wildcard “*” to a search string.
Type too small? In most browsers, press Control “+” to enlarge type size. Reset by pressing Control “0”.
Results. To view an abstract, click on a title within results. Presenters’ names are underlined among the list of authors.
Browser Compatibility
For the best user experience on this or any website, it is important that your browser remain up-to-date with current standards.
We support Microsoft Internet Explorer 10+, Microsoft Edge, Mozilla Firefox, Google Chrome and any other modern web browser compatible with HTML5 and CSS3.